Ads
related to: paxlovid side effects blood clots
Search results
Results From The WOW.Com Content Network
Paxlovid Side Effects The most common side effect of Paxlovid is an altered sense of taste, according to the FDA. The medication also has an unpleasant, metallic taste, Dr. Gupta says.
“Paxlovid is an important treatment and critical tool in the fight against COVID-19.” ... as well as clinical monitoring for side effects and follow-up care to determine whether a patient is ...
When the antiviral medication Paxlovid was approved in 2021 to treat COVID-19, doctors began noticing a trend among some patients: a rebound case of the virus. After treatment, some people would ...
Nirmatrelvir/ritonavir is under investigation, so its side effects have yet to be fully evaluated and may not be completely known. [ 19 ] Other side effects of nirmatrelvir/ritonavir may include hypersensitivity reactions , liver toxicity , and development of HIV drug resistance in people with uncontrolled or undiagnosed HIV infection .
Disseminated intravascular coagulation (DIC), diffuse formation of blood clots throughout the blood vessels of the body, has been reported as part of the syndrome. [27] DIC may cause a range of symptoms, including abnormal bleeding, breathlessness, chest pain, neurological symptoms, low blood pressure, or swelling.
Coronaviral proteases cleave multiple sites in the viral polyprotein, usually after there are glutamine residues. Early work on related human rhinoviruses showed that the flexible glutamine side chain in inhibitors could be replaced by a rigid pyrrolidone.
Researchers said their work is the biggest study of its kind on this issue and helps put the risks into context.
Common side effects of ritonavir include nausea, vomiting, loss of appetite, diarrhea, and numbness of the hands and feet. [8] Serious side effects include liver complications, pancreatitis, allergic reactions, and arrhythmias. [8] Serious interactions may occur with a number of other medications including amiodarone and simvastatin. [8]